GALT Latest Press Releases

-- December 19, 2025 --

Galectin Therapeutics Provides Regulatory Update Following FDA Written Response and Announces an Additional $10 Million Line of Credit from Richard E. Uihlein Sufficient to Cover Expected Expenditures Through March 2027 Globe Newswire 8:00 AM

-- November 14, 2025 --

Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update Globe Newswire 8:00 AM

-- November 10, 2025 --

Galectin Therapeutics Presented NAVIGATE Trial Results at the American Association for the Study of Liver Diseases (AASLD) 2025 Annual Meeting Globe Newswire 8:00 AM

-- October 20, 2025 --

Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference Globe Newswire 8:00 AM

-- October 7, 2025 --

Galectin Therapeutics to Present at the American Association for the Study of Liver Disease (AASLD) Liver Meeting 2025 Globe Newswire 8:00 AM

-- September 2, 2025 --

Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference Globe Newswire 8:00 AM

-- August 14, 2025 --

Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2025 and Provides Business Update Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software